Evidence map›Paper›PMID 29475932›Full record

ArticleIn vivo (Athens, Greece)

Differences in Urinary Amino Acid Patterns in Individuals with Different Types of Urological Tumor Urinary Amino Acid Patterns as Markers of Urological Tumors.

Katerina Duskova, Stepan Vesely, Joana DO Carmo Silva, Natalia Cernei, Ondrej Zitka, Zbynek Heger, Vojtech Adam, Klara Havlova, Marek Babjuk

Open access · diamondAbstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Mass spectrometry imaging of L-[ring-Cancer & metabolism · 2021
    Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Katerina DuskovaDepartment of Urology, Second Faculty of Medicine, Charles University, and University Hospital Motol, Prague, Czech Republic katerina.duskova@fnmotol.cz.
Stepan VeselyDepartment of Urology, Second Faculty of Medicine, Charles University, and University Hospital Motol, Prague, Czech Republic.
Joana DO Carmo SilvaDepartment of Urology, Second Faculty of Medicine, Charles University, and University Hospital Motol, Prague, Czech Republic.
Natalia CerneiCentral European Institute of Technology, Brno University of Technology, Brno, Czech Republic.
Ondrej ZitkaCentral European Institute of Technology, Brno University of Technology, Brno, Czech Republic.
Zbynek HegerCentral European Institute of Technology, Brno University of Technology, Brno, Czech Republic.
Vojtech AdamCentral European Institute of Technology, Brno University of Technology, Brno, Czech Republic.
Klara HavlovaDepartment of Urology, Second Faculty of Medicine, Charles University, and University Hospital Motol, Prague, Czech Republic.
Marek BabjukDepartment of Urology, Second Faculty of Medicine, Charles University, and University Hospital Motol, Prague, Czech Republic.
University Hospital in Motol · CZCentral European Institute of Technology · CZBrno University of Technology · CZMendel University in Brno · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInsufficient specificity and invasiveness of currently used diagnostic methods raises the need for new markers of urological tumors. The aim of this study was to find a link between the urinary excretion of amino acids and the presence of urological tumors. MATERIALS AND

methodsUsing ion-exchange chromatography, we tested urine samples of patients with prostate cancer (n=30), urinary bladder cancer (n=28), renal cell carcinoma (n=16) and healthy volunteers (control group; n=21).

resultsIn each category, we found a group of amino acids which differed in concentration compared to the control group. These differences were most significant in sarcosine in patients with prostate cancer; leucine, phenylalanine and arginine in those with bladder cancer; and sarcosine, glutamic acid, glycine, tyrosine and arginine in the those with renal cell carcinoma.

conclusionResults of our research imply a possible connection between the occurrence of specific types of amino acids in the urine and the presence of urological tumors.

Indexed as

Biomarkers, TumorAdultAgedAged, 80 and overAmino AcidsChromatography, Ion ExchangeDiagnosis, DifferentialFemaleHumansKidney NeoplasmsMaleMiddle AgedNeoplasm StagingProstate-Specific AntigenProstatic NeoplasmsSensitivity and SpecificityAmino AcidsBiomarkers, TumorProstate-Specific AntigenAmino acidsprostate cancerrenal cell carcinomaurinary bladder cancer

Identifiers

PMID29475932
PMCPMC5905217
OpenAlexW2788261491

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.